Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 467 entries
View as:

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT06649201 Org: User:
Start: 12/19/24 End: 02/15/27 Due: 02/15/28

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00258401 Org: User:
Start: 05/31/05 End: 06/30/06 Due: 06/30/07

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00619515 Org: User:
Start: 12/31/07 End: 02/28/13 Due: 02/28/14

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Phase: N/A Priority: Normal
NCT ID: NCT04194840 Org: User:
Start: 05/01/21 End: 06/30/26 Due: 06/30/27

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00005647 Org: User:
Start: 05/31/00 End: 10/31/03 Due: 10/31/04

Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT00769249 Org: User:
Start: 02/29/08 End: - Due: -

Intra-Osseous Co-Transplant of UCB and hMSC

Phase: N/A Priority: Normal
NCT ID: NCT02181478 Org: User:
Start: 07/22/15 End: 02/07/20 Due: 02/07/21

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Phase: N/A Priority: Normal
NCT ID: NCT01100528 Org: User:
Start: 11/11/09 End: 12/14/17 Due: 12/14/18

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02103634 Org: User:
Start: 03/01/14 End: 12/21/18 Due: 12/21/19

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT00750009 Org: User:
Start: 04/30/08 End: 12/31/12 Due: 12/31/13

Quality of Life in Younger Leukemia and Lymphoma Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00956475 Org: User:
Start: 10/31/08 End: 08/31/11 Due: 08/31/12

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

Phase: N/A Priority: Normal
NCT ID: NCT02581839 Org: User:
Start: 11/17/15 End: 07/02/20 Due: 07/02/21

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01939028 Org: User:
Start: 07/31/13 End: 10/31/16 Due: 10/31/17

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005981 Org: User:
Start: 06/30/00 End: 11/30/03 Due: 11/30/04

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006864 Org: User:
Start: 07/31/00 End: 07/31/07 Due: 07/31/08

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT00733252 Org: User:
Start: 04/30/08 End: 02/28/11 Due: 02/28/12

Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02383433 Org: User:
Start: 06/14/16 End: 05/10/18 Due: 05/10/19

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00905086 Org: User:
Start: 08/31/08 End: 05/31/09 Due: 05/31/10

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

Phase: N/A Priority: Normal
NCT ID: NCT01557881 Org: User:
Start: 02/29/12 End: 04/30/15 Due: 04/30/16

Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03583736 Org: User:
Start: 06/27/18 End: 06/01/20 Due: 06/01/21

Spine Radiosurgery for Symptomatic Metastatic Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT05617716 Org: User:
Start: 01/25/23 End: 12/31/26 Due: 12/31/27

Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04055948 Org: User:
Start: 12/17/19 End: 06/30/25 Due: 06/30/26

Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00900133 Org: User:
Start: 01/31/05 End: 12/31/06 Due: 12/31/07

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01158534 Org: User:
Start: 03/31/06 End: 10/31/10 Due: 10/31/11

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04332341 Org: User:
Start: 05/19/20 End: 09/30/26 Due: 09/30/27